Vnitr Lek 2014, 60(10):817-818

Czech TAVI Registry. Potrebujeme registre? - editorial

Viliam Fridrich
Oddelenie intervenčnej kardiológie Národného ústavu srdcových a cievnych chorôb, a.s., Bratislava, Slovenská republika, primár MUDr. Viliam Fridrich, PhD.

Received: April 5, 2014; Published: October 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fridrich V. Czech TAVI Registry. Potrebujeme registre? - editorial. Vnitr Lek. 2014;60(10):817-818.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24(13): 1231-1243. Go to original source... Go to PubMed...
    2. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111(7): 920-925. Go to original source... Go to PubMed...
    3. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med 1987; 317(2): 91-98. Go to original source... Go to PubMed...
    4. Stephan PJ, Henry AC, Hebeler RF et al. Comparison of age, gender, number of aortic valve cusps, concomitant coronary artery bypass grafting, and magnitude of left ventricular-systemic arterial peak systolic gradient in adults having aortic valve replacement for isolated aortic valve stenosis. Am J Cardiol 1997; 79(2): 166-172. Go to original source... Go to PubMed...
    5. Gardin JM, Kaplan KJ, Meyers SN et al. Aortic stenosis: can severity be reliably estimated noninvasively? Chest 1980; 77(2): 130-131. Go to original source... Go to PubMed...
    6. Leon MB, Smith RS, Mack M et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363(17): 1597-1607. Go to original source... Go to PubMed...
    7. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28(2): 230-268. Go to original source... Go to PubMed...
    8. Andersen HR, Knudsen LL, Hasenkam JM Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992; 13(5): 704-708. Go to original source... Go to PubMed...
    9. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106(24): 3006-3008. Go to original source... Go to PubMed...
    10. Smith CR, Leon MB, Mack MJ et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high risk patients. N Engl J Med 2011; 364(23): 2187-2198. Go to original source... Go to PubMed...
    11. Busca IR, Brasseur P, Piana N. Variations in TAVI rates across 14 countries over two years. Eurointervention 2012; 8(Suppl N): 331.
    12. Blaha M, Kala P, Klimeš D et al. Uživatelské výstupy z národního registru katetrových implantací aortální chlopně (Czech TAVI Registry): možnosti analytických výstupu založených na databázového systému TrialDB2. Vnitř Lék 2014; 60(10): 837-845. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.